Cerebral Metastases of Cutaneous Melanoma
Author Information
Author(s): G Gupta, AG Robertson, RM MacKie
Primary Institution: University of Glasgow
Conclusion
Patients with cerebral metastases from cutaneous melanoma have a median survival of 4 months, and treatment options show limited effectiveness.
Supporting Evidence
- Median survival for patients with one cerebral metastasis was 5 months, while those with multiple metastases had a median survival of 3 months.
- Patients with cerebral metastases alone had a median survival of 6.5 months compared to 3 months for those with additional metastases.
- Radiotherapy and dexamethasone provided symptom relief but did not improve overall survival compared to dexamethasone alone.
Takeaway
This study looked at patients with brain tumors caused by skin cancer and found that most don't live long after diagnosis, even with treatment.
Methodology
The study analyzed 31 patients diagnosed with cerebral metastases from melanoma over a 5-year period, collecting data on demographics, treatment, and outcomes.
Limitations
The study did not evaluate patients who were asymptomatic and did not undergo CT scans.
Participant Demographics
16 men (52%) and 15 women (48%), aged from the third to the seventh decade.
Statistical Information
P-Value
0.03
Statistical Significance
p=0.03
Want to read the original?
Access the complete publication on the publisher's website